Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stubbs

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|February 28, 2013
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophyChad D Touchberry, Troy M Green, Vladimir Tchikrizov, et al.
Prehospital Emergency Care|October 20, 2021
THOR-AABB Working Party Recommendations for a Prehospital Blood Product Transfusion ProgramMark H Yazer, Philip C Spinella, Eric A Bank, et al.
Blood Advances|September 26, 2022
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19Juan G Ripoll, Ellen K Gorman, Justin E Juskewitch, et al.
Trials|August 3, 2025
Trauma resuscitation with Low-Titer Group O Whole Blood Or Products: study protocol for a randomized clinical trial (the TROOP trial)Jan O Jansen, Claudia Pedroza, Luis Leon Novelo, et al.
Academic Pathology|September 7, 2018
Report and Recommendations of the Association of Pathology Chairs' Autopsy Working GroupGregory G Davis, Gayle L Winters, Billie S Fyfe, et al.
Transfusion|June 22, 2022
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysisJeremy W Cannon, Noah M Igra, P Dayand Borge, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Scientific Reports|January 13, 2022
Coagulation profile of human COVID-19 convalescent plasmaAllan M Klompas, Noud van Helmond, Justin E Juskewitch, et al.
Frontiers in Molecular Biosciences|December 16, 2022
Caspase-1 and the inflammasome promote polycystic kidney disease progressionKatherine I Swenson-Fields, Christopher J Ward, Micaila E Lopez, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Physiology. Endocrinology and Metabolism|February 28, 2013
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophyChad D Touchberry, Troy M Green, Vladimir Tchikrizov, et al.
Prehospital Emergency Care|October 20, 2021
THOR-AABB Working Party Recommendations for a Prehospital Blood Product Transfusion ProgramMark H Yazer, Philip C Spinella, Eric A Bank, et al.
Blood Advances|September 26, 2022
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19Juan G Ripoll, Ellen K Gorman, Justin E Juskewitch, et al.
Trials|August 3, 2025
Trauma resuscitation with Low-Titer Group O Whole Blood Or Products: study protocol for a randomized clinical trial (the TROOP trial)Jan O Jansen, Claudia Pedroza, Luis Leon Novelo, et al.
Academic Pathology|September 7, 2018
Report and Recommendations of the Association of Pathology Chairs' Autopsy Working GroupGregory G Davis, Gayle L Winters, Billie S Fyfe, et al.
Transfusion|June 22, 2022
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysisJeremy W Cannon, Noah M Igra, P Dayand Borge, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Scientific Reports|January 13, 2022
Coagulation profile of human COVID-19 convalescent plasmaAllan M Klompas, Noud van Helmond, Justin E Juskewitch, et al.
Frontiers in Molecular Biosciences|December 16, 2022
Caspase-1 and the inflammasome promote polycystic kidney disease progressionKatherine I Swenson-Fields, Christopher J Ward, Micaila E Lopez, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Pageof 16